BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21747033)

  • 1. Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease.
    Godau J; Knauel K; Weber K; Brockmann K; Maetzler W; Binder G; Berg D
    Arch Neurol; 2011 Jul; 68(7):925-31. PubMed ID: 21747033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease.
    Mashayekhi F; Mirzajani E; Naji M; Azari M
    J Clin Neurosci; 2010 May; 17(5):623-7. PubMed ID: 20189394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia.
    Ning Y; Williams MA; Vadachkoria S; Muy-Rivera M; Frederick IO; Luthy DA
    Clin Biochem; 2004 Nov; 37(11):968-73. PubMed ID: 15498523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diet on serum insulin-like growth-factor-I and its main binding proteins.
    Allen NE; Appleby PN; Davey GK; Key TJ; Rinaldi S; Kaaks R
    IARC Sci Publ; 2002; 156():295-6. PubMed ID: 12484190
    [No Abstract]   [Full Text] [Related]  

  • 8. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of dementia in Parkinson's disease over 54 months.
    Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG
    Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL; Thomas W; Schmitz KH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation.
    Raynaud-Simon A
    J Nutr Health Aging; 2003; 7(4):267-73. PubMed ID: 12917753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free insulin-like growth factor-I and cognitive function in older persons living in community.
    Landi F; Capoluongo E; Russo A; Onder G; Cesari M; Lulli P; Minucci A; Pahor M; Zuppi C; Bernabei R
    Growth Horm IGF Res; 2007 Feb; 17(1):58-66. PubMed ID: 17208483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.